Leukemia-initiating HSCs in chronic lymphocytic leukemia reveal clonal leukemogenesis and differential drug sensitivity-Reference-Cited by-同舟云学术

Leukemia-initiating HSCs in chronic lymphocytic leukemia reveal clonal leukemogenesis and differential drug sensitivity

Published:2022-07 Issue:3 Volume:40 Page:111115
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Chiang Chi-Ling,Hu Eileen Y.,Chang Lingqian,Labanowska Jadwiga,Zapolnik Kevan^ORCID,Mo Xiaokui,Shi Junfeng,Doong Tzyy-Jye,Lozanski Arletta,Yan Pearlly S.,Bundschuh Ralf^ORCID,Walker Logan A.^ORCID,Gallego-Perez Daniel,Lu Wu^ORCID,Long Meixiao,Kim Sanggu,Heerema Nyla A.,Lozanski Gerard,Woyach Jennifer A.,Byrd John C.,Lee Ly James,Muthusamy Natarajan^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference55 articles.

1. Single cell gene expression analysis of pluripotent stem cells;Abruzzese;Methods Mol. Biol.,2013

2. A clinical staging system for chronic lymphocytic leukemia: prognostic significance;Binet;Cancer,1977

3. Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia;Byrd;N. Engl. J. Med.,2013

4. Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011;Byrd;Blood,2005

5. Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance);Byrd;Blood Adv.,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mouse models of chronic lymphocytic leukemia and Richter transformation: what we have learnt and what we are missing;Frontiers in Immunology;2024-06-06

2. Mouse models of CLL: In vivo modeling of disease initiation, progression, and transformation;Seminars in Hematology;2024-06

3. Persistence of Chronic Lymphocytic Leukemia Stem-like Populations under Simultaneous In Vitro Treatment with Curcumin, Fludarabine, and Ibrutinib: Implications for Therapy Resistance;International Journal of Molecular Sciences;2024-02-07